Diabetic Nephropathy
- Zachary T. Bloomgarden, MD, is a practicing endocrinologist in New York, New York, and is affiliated with the Division of Endocrinology, Mount Sinai School of Medicine, New York, New York
Abstract
Perspectives on the News commentaries are part of a free monthly CME activity. The Mount Sinai School of Medicine, New York, New York, designates this activity for 2.0 AMA PRA Category 1 credits. If you wish to participate, review this article and visit www.diabetes.procampus.net to complete a posttest and receive a certificate. The Mount Sinai School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- ACEI, angiotensin-converting enzyme inhibitor
- ARB, angiotensin receptor blocker
- CKD, chronic kidney disease
- CRP, C-reactive protein
- CVD, cardiovascular disease
- EPC, endothelial progenitor cell
- ESRD, end-stage renal disease
- GFR, glomerular filtration rate
- NO, nitric oxide
- PKC, protein kinase C
- TGF, transforming growth factor
Footnotes
- DIABETES CARE
